News

This milestone demonstrates Theralase’s ability to consistently and reliably manufacture its lead light activated drug in the same purity and yield as the original GMP batch. Consistency in

Swereco markets OTC products mainly to pharmacies or directly to health care providers. Net sales in 2014 were 150 MSEK. There are several well-established brands in the product

The move forms part of the company’s "Fit for 2018" strategic transformation and growth program, which includes the focus on innovative, technology-driven businesses as well as the modernization

The funds were raised in a mezzanine financing round from all its existing investors, including Nordic investors Investinor and Industrifonden. Pharmalink will use the money to prepare a

Third Rock Ventures led the funding round, which also included financing from Clal Biotechnology Industries and Access Industries. Neon Therapeutics was founded by experts in neoantigen biology, tumor

Under this agreement, Biohaven will provide $1.5M in research funding to FCCDC to advance a lead prodrug candidate to IND filing. FCCDC is a Pennsylvania based drug discovery

Through this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets globally.

LHON is a rare inherited mitochondrial disease that usually leads rapidly to profound and permanent blindness. Santhera chief commercial officer for Europe Giovanni Stropoli said: "The introduction of

Today’s announcement marks the first and only FDA approval of a Regimen of two Immuno-Oncology agents in cancer. This indication is approved under accelerated approval based on tumor